Advertisement

Lymphomas mimicking neuroinflammatory diseases – A diagnostic conundrum worth revisiting

Published:September 14, 2022DOI:https://doi.org/10.1016/j.jneuroim.2022.577970

      Abstract

      Purpose of review

      Central nervous system (CNS) lymphomas (CNSLs) have varied clinical presentations which can mimic neuroinflammatory disease, leading to a diagnostic dilemma for clinicians.

      Recent findings

      This report describes two patients who initially received a diagnosis of neuroinflammatory disorders but were refractory to treatment over a protracted time course. In both cases, biopsy revealed diffuse large B cell lymphoma (DLBCL) as the final diagnosis.

      Summary

      The analysis of these cases provides an opportunity for increased recognition of CNS lymphomas for earlier diagnosis and treatment. It also calls for increased clinical suspicion for CNSLs in such circumstances. And possibly the search for new biomarker development for identifying and tracking CNSLs.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Neuroimmunology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Alderson L.
        • Fetell M.R.
        • Sisti M.
        • Hochberg F.
        • Cohen M.
        • Louis D.N.
        Sentinel lesions of primary CNS lymphoma.
        J. Neurol. Neurosurg. Psychiatry. 1996; 60: 102-105
        • Allen C.E.
        • Merad M.
        • McClain K.L.
        Langerhans-cell histiocytosis.
        N. Engl. J. Med. 2018; 379: 856-868
        • Araki K.
        • Harada K.
        • Nakamoto K.
        • Shiroma M.
        • Miyakuni T.
        Clinical significance of serum soluble IL-2R levels in patients with adult T cell leukaemia (ATL) and HTLV-1 carriers.
        Clin. Exp. Immunol. 2000; 119: 259-263
        • Baraniskin A.
        • Kuhnhenn J.
        • Schlegel U.
        • Chan A.
        • Deckert M.
        • Gold R.
        • et al.
        Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system.
        Blood. 2011; 117: 3140-3146
        • Biswas S.N.
        • Barman H.
        • Sarkar T.S.
        • Chakraborty P.P.
        Physiological pituitary hyperplasia misinterpreted and treated as lymphocytic hypophysitis.
        BMJ Case Rep. 2018; 2018
        • Bradshaw M.J.
        • Pawate S.
        • Koth L.L.
        • Cho T.A.
        • Gelfand J.M.
        Neurosarcoidosis: pathophysiology, diagnosis, and treatment.
        Neurol. Neuroimmunol. Neuroinflamm. 2021; 8
        • Bridel C.
        • Courvoisier D.S.
        • Vuilleumier N.
        • Lalive P.H.
        Cerebrospinal fluid angiotensin-converting enzyme for diagnosis of neurosarcoidosis.
        J. Neuroimmunol. 2015; 285: 1-3
        • Deckert M.
        • Brunn A.
        • Montesinos-Rongen M.
        • Terreni M.R.
        • Ponzoni M.
        Primary lymphoma of the central nervous system--a diagnostic challenge.
        Hematol. Oncol. 2014; 32: 57-67
        • Eurelings L.E.M.
        • Miedema J.R.
        • Dalm V.
        • van Daele P.L.A.
        • van Hagen P.M.
        • van Laar J.A.M.
        • et al.
        Sensitivity and specificity of serum soluble interleukin-2 receptor for diagnosing sarcoidosis in a population of patients suspected of sarcoidosis.
        PLoS One. 2019; 14e0223897
        • Feldman L.
        • Li Y.
        • Ontaneda D.
        Primary CNS lymphoma initially diagnosed as vasculitis.
        Neurol. Clin. Pract. 2020; 10: 84-88
        • Giannini C.
        • Dogan A.
        • Salomao D.R.
        CNS lymphoma: a practical diagnostic approach.
        J. Neuropathol. Exp. Neurol. 2014; 73: 478-494
        • Ginat D.T.
        • Dhillon G.
        • Almast J.
        Magnetic resonance imaging of neurosarcoidosis.
        J. Clin. Imag. Sci. 2011; 1: 15
        • Hammoud D.A.
        • Munter F.M.
        • Brat D.J.
        • Pomper M.G.
        Magnetic resonance imaging features of pituicytomas.
        Analysis of 10 Cases. 2010; 34: 757-761
        • Korfel A.
        • Schlegel U.
        Diagnosis and treatment of primary CNS lymphoma.
        Nat. Rev. Neurol. 2013; 9: 317-327
        • Lee C.H.
        • Bharwani L.
        • Sullivan T.
        Paraneoplastic necrotizing myelopathy in a patient with newly diagnosed diffuse large B cell lymphoma.
        World J. Oncol. 2011; 2: 195-198
        • Louveau A.
        • Harris T.H.
        • Kipnis J.
        Revisiting the mechanisms of CNS immune privilege.
        Trends Immunol. 2015; 36: 569-577
        • Malikova H.
        • Koubska E.
        • Weichet J.
        • Klener J.
        • Rulseh A.
        • Liscak R.
        • et al.
        Can morphological MRI differentiate between primary central nervous system lymphoma and glioblastoma?.
        Cancer Imaging. 2016; 16: 40
        • Molitch M.E.
        Diagnosis and treatment of pituitary adenomas: a review.
        JAMA. 2017; 317: 516-524
        • Muller H.L.
        • Merchant T.E.
        • Warmuth-Metz M.
        • Martinez-Barbera J.P.
        • Puget S.
        Craniopharyngioma.
        Nat. Rev. Dis. Primers. 2019; 5: 75
        • Rosenfield N.S.
        • Abrahams J.
        • Komp D.
        Brain MR in patients with Langerhans cell histiocytosis: findings and enhancement with Gd-DTPA.
        Pediatr. Radiol. 1990; 20: 433-436
        • Scott B.J.
        • Douglas V.C.
        • Tihan T.
        • Rubenstein J.L.
        • Josephson S.A.
        A systematic approach to the diagnosis of suspected central nervous system lymphoma.
        JAMA Neurol. 2013; 70: 311-319
        • Stern B.J.
        • Royal 3rd, W.
        • Gelfand J.M.
        • Clifford D.B.
        • Tavee J.
        • Pawate S.
        • et al.
        Definition and consensus diagnostic criteria for neurosarcoidosis: from the neurosarcoidosis consortium consensus group.
        JAMA Neurol. 2018; 75: 1546-1553
        • Tong Y.
        • Sirhan D.
        • Cortes M.
        Preoperative diagnosis of Suprasellar Hemangioblastoma with four-dimensional computed tomography angiography: case report and literature review.
        Indian J. Radiol. Imag. 2021; 31: 499-509
        • Wingerchuk D.M.
        • Banwell B.
        • Bennett J.L.
        • Cabre P.
        • Carroll W.
        • Chitnis T.
        • et al.
        International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.
        Neurology. 2015; 85: 177-189
        • Zajicek J.P.
        • Scolding N.J.
        • Foster O.
        • Rovaris M.
        • Evanson J.
        • Moseley I.F.
        • et al.
        Central nervous system sarcoidosis--diagnosis and management.
        QJM. 1999; 92: 103-117